🇺🇸 FDA
Patent

US 8080672

Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

granted A61PA61P3/06A61P43/00

Quick answer

US patent 8080672 (Crystal form of atorvastatin hemi-calcium and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P3/06, A61P43/00, A61P9/00, A61P9/10